{"id":"W3110464061","doi":"10.1016/j.annonc.2020.10.437","title":"217O Pembrolizumab (pembro) combination therapies in patients with metastatic castration-resistant prostate cancer (mCRPC): Cohorts A-C of the phase Ib/II KEYNOTE-365 study","year":2020,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"ca_institutions":"Western University; Princess Margaret Cancer Centre","funders":"Merck Sharp and Dohme","keywords":"Medicine; Cohort; Enzalutamide; Abiraterone acetate; Docetaxel; Abiraterone; Prostate cancer; Internal medicine; Cancer; Oncology; Androgen deprivation therapy; Androgen receptor","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001107697,0.0007208851,0.001292501,0.0002980698,0.0003564079,0.0009668689,0.0004728156,0.0006404595,0.003229063],"category_scores_gemma":[0.0006893313,0.0003282808,0.001490535,0.0005007015,0.0004467998,0.0007182009,0.0003406204,0.002118157,0.0007489816],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0009572575,"about_ca_system_score_gemma":0.001207699,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00246443,"about_ca_topic_score_gemma":0.0087424,"domain_scores_codex":[0.9996371,0.0001538798,0.000020152,0.00006197198,0.00004264991,0.00008421794],"domain_scores_gemma":[0.9996511,0.00005765234,0.00008379474,0.00002414612,0.00002166284,0.0001616844],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.8116775,0.01220443,0.01739063,0.001823029,0.003992418,0.0001262612,0.0002020495,0.002006804,0.009775373,0.0005253505,0.01051307,0.1297631],"study_design_scores_gemma":[0.7562919,0.1555442,0.06474033,0.0002895344,0.003627842,0.0003207699,0.0001993725,0.001419992,0.001959561,0.0007522645,0.01478296,0.00007124502],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9795712,0.01030854,0.000340399,0.0009089945,0.0002287637,0.0008692049,0.003128933,0.00006978587,0.004574117],"genre_scores_gemma":[0.9849031,0.005428597,0.0009084338,0.00122731,0.000203363,0.0005434959,0.003986243,0.00002333563,0.002776161],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003229063,"threshold_uncertainty_score":0.01080227,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0810000559258849,"score_gpt":0.407301675363801,"score_spread":0.3263016194379161,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}